Biosimilar Uptake: The Importance of Healthcare Provider Education
Pharmaceutical Medicine · 2021-07 · 35 (4) · 215-224
DOI: 10.1007/s40290-021-00396-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Medicine, online erschienen am 22.08.2021. Verfasst von Sonia Tadjalli Oskouei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardinal Health, 7000 Cardinal Place, Dublin, OH, 43017, USA. sonia.oskouei@cardinalhealth.com. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pending.
Abstract (Originalsprache)
From peptide hormones to monoclonal antibodies, advances in biotherapeutic medicines, or biologics, have brought incalculable benefits to patients, especially for conditions where previous classes of therapy were ineffective or non-existent. At the same time, the development of biologics has been accompanied by questions of access and cost. The advent of biosimilars, molecules highly similar to their reference biologics, has offered the promise of ameliorating cost and access challenges. However, issues regarding biosimilar uptake remain. Multiple factors impact the utilization of biosimilars by healthcare providers and perhaps the best recognized of these is education. This paper discusses the importance of education to biosimilar adoption and lists action-items that various stakeholders in healthcare can adopt to improve the overall understanding of this important class of therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardinal Health, 7000 Cardinal Place, Dublin, OH, 43017, USA. sonia.oskouei@cardinalhealth.com.
- Cardinal Health, 7000 Cardinal Place, Dublin, OH, 43017, USA.
ORCID-Profile: Sonia Tadjalli Oskouei
Förderung
- Pending
Zitieren
APA
Oskouei, S. T., & Kusmierczyk, A. R. (2021). Biosimilar Uptake: The Importance of Healthcare Provider Education. Pharmaceutical Medicine, 35(4), 215-224. https://doi.org/10.1007/s40290-021-00396-7
Vancouver
Oskouei ST, Kusmierczyk AR. Biosimilar Uptake: The Importance of Healthcare Provider Education. Pharmaceutical Medicine. 2021;35(4):215-224. doi:10.1007/s40290-021-00396-7
BibTeX
@article{Oskouei2021,
author = {Oskouei, Sonia Tadjalli and Kusmierczyk, Andrew R},
title = {Biosimilar Uptake: The Importance of Healthcare Provider Education},
journal = {Pharmaceutical Medicine},
year = {2021},
volume = {35},
number = {4},
pages = {215--224},
doi = {10.1007/s40290-021-00396-7}
}
EUVIMED